China (Mainland)
Nivolumab (anti-PD-1) CAS NO.946414-94-4
- Min.Order: 10 Milligram
- Payment Terms: T/T,
- Product Details
Keywords
- Nivolumab (anti-PD-1)
- Nivolumab
- 946414-94-4
Quick Details
- ProName: Nivolumab (anti-PD-1)
- CasNo: 946414-94-4
- Molecular Formula: C6362H9862N1712O1995S42
- Application: Nivolumab (anti-PD-1) is a genetically...
- ProductionCapacity: Kilogram/Month
- Purity: 98%
- LimitNum: 10 Milligram
Superiority
Nivolumab (anti-PD-1) is a genetically engineered, fully human immunoglobulin (Ig) G4 monoclonal antibody directed against the negative immunoregulatory human cell surface receptor programmed death-1 (PD-1,PCD-1) with immune checkpoint inhibitory and antineoplastic activities.
Details
|
Name |
Nivolumab (anti-PD-1) |
|
CAS NO. |
946414-94-4 |
|
Type |
Whole antibody |
|
Source |
Human |
|
Target |
PD-1 |
|
Clone |
Monoclone |
|
Molecular Weight |
146 kDa |
|
Formula |
C6362H9862N1712O1995S42 |
|
Antibody Form |
Purified immunoglobulin |
|
Physical Form |
Solution |
|
Grade Standard |
Medicine Grade |
|
Place of Origin |
China(Mainland) |
|
Storage |
-70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light. |
Nivolumab is a fully human IgG4 antibody targeting the immune checkpoint programmed death receptor-1 (PD-1).
For research use only. Not for use in humans.